The use of zebrafish as an animal model to study cardiomyopathy was initially reported in 2002, when Xu et al. identified a titin mutant and Sehnertet al. cloned a tnnt2 mutant, representing two embryonic zebrafish forms of cardiomyopathy [9,10]. This evidence concerns the gene TNNT2 and cardiomyopathy.